共 50 条
Accurate quantification of CXCR4-using HIV-1 variants by Illumina deep-sequencing
被引:0
|作者:
Raymond, Stephanie
[1
,2
]
Delaugerre, Constance
[3
,4
]
Nicot, Florence
[1
]
Assoumou, Lambert
[5
]
Lancar, Remi
[5
]
Beniguel, Lydie
[5
]
Izopet, Jacques
[1
]
机构:
[1] CPTP, CNRS, UMR 5282, INSERM,U1043, Toulouse, France
[2] CHU Toulouse Purpan, Virol Lab, F-31300 Toulouse, France
[3] Hop St Louis, Assistance Publ Hop Paris, Virol, Paris, France
[4] Univ Paris Diderot, INSERM UMR 941, Sorbonne Paris Cite, Paris, France
[5] Sorbonne Univ, INSERM, IPLESP, Paris, France
来源:
关键词:
CORECEPTOR USAGE;
MARAVIROC;
TROPISM;
D O I:
10.1097/QAD.0000000000001976
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
Next-generation sequencing is a sensitive method for determining HIV-1 tropism but there is a lack of data on the quantification of X4 variants. We evaluated MiSeq and 454 GS-Junior platforms for determining HIV-1 tropism and for quantifying X4 variants. Both platforms were 93% concordant for determining HIV-1 tropism and correlated well for determining the proportion of X4 variants (Spearman correlation, p = 0.748; P < 0.0001). MiSeq Illumina sequencing seems to be well adapted for characterizing X4-containing samples.
引用
收藏
页码:2429 / 2431
页数:3
相关论文